An attorney with diverse experience, Ilan serves as legal counsel to a variety of Israeli commercial entities, advising on all aspects of corporate law and cooperative societies. He particularly specializes in mergers and acquisitions and antitrust law.
Ilan accompanies the firm’s clients in complex corporate and commercial transactions, including capital raising, financing, investments, and restructuring. He also handles bank arrangements and the purchasing of businesses in cash flow distress.
In the area of antitrust, Ilan advises the firm’s clients on various matters, including mergers and acquisitions, restrictive arrangements, concentration groups, monopolies, and operation of market force. He also represents clients before the Antitrust Authority and the Antitrust Tribunal, as necessary.
Ilan serves as legal counsel to several business associations with regard to competition and antitrust laws, and represents business associations in various actions vis-à-vis the governmental authorities.
Ilan provides legal services to corporations from various sectors, including high tech, agro-technology, food, industry, and green technology. He also represents various corporations belonging to the kibbutz sector.
Interdisciplinary Center Herzliya (LL.B, B.A Major in Marketing), 2005
Member of Israel Bar Association since 2006
News and updates - Ilan Blumenfeld:
Entities with Relatively Small Market Shares May Also Be Deemed Monopolies
Six months after the amendment to the Economic Competition Law took effect, the Competition Authority published its position regarding the circumstances in which even an entity with less than a 50% market share may be deemed a "monopoly holder."
Barnea Representing Azrieli Group in Sale of Holdings in Supergas
Our firm represented Azrieli Group in the sale of its holdings in Supergas to Elco Group for NIS 1 billion. Azrieli was represented by Advs. Micky Barnea, Yuval Lazi, Ilan Blumenfeld, Sagi Gross and Daniel Kleinman.
Barnea Represented Danel Ltd. in the Acquisition of Levinger Group
Our firm represented Danel Ltd. in a deal to acquire 51% of Levinger Group. This marks a strategic move by Danel to expand into the private health field.